4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-21-048385
Director acquired 4,760,510 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DENG FENG Director | 2021-07-22 | Conversion | +147,933 | 147,933 | I | ||
| DENG FENG Director | 2021-07-22 | Conversion | +4,168,777 | 4,168,777 | I | ||
| DENG FENG Director | 2021-07-22 | Conversion | +443,800 | 443,800 | I | ||
| Derivatives | |||||||
| DENG FENG Director | 2021-07-22 | Conversion · Series A Preferred Stock | −147,933 | 0 | I | ||
| DENG FENG Director | 2021-07-22 | Conversion · Series C Preferred Stock | −4,168,777 | 0 | I | ||
| DENG FENG Director | 2021-07-22 | Conversion · Series D Preferred Stock | −443,800 | 0 | I | ||
Loading xslF345X03/doc4.xml…